MapLight Therapeutics, Inc. (MPLT) vs Rezolute, Inc. (RZLT)

A side-by-side comparison of MapLight Therapeutics, Inc. and Rezolute, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
MapLight Therapeutics, Inc. logo
MPLT
MapLight Therapeutics, Inc.
$411M
$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Rezolute, Inc. logo
RZLT
Rezolute, Inc.
$416M
$4.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MPLT vs RZLT

growth of $100 · dividends reinvested · last 1y
MPLT -49.4% (-49.4%/yr)RZLT -54.2% (-54.2%/yr)MPLT compounded faster over this window
050100150200Start $1002026$51$46
MPLT RZLT

MPLT vs RZLT: by the numbers

  • •RZLT is the larger company ($416M vs $411M market cap).

Metrics side by side

Valuation

MetricMPLTRZLT
P/B ratio1.184.13

Profitability

MetricMPLTRZLT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-65.99%-77.06%
ROIC-69.35%-81.80%

Growth (annualized)

MetricMPLTRZLT
Total return CAGR (5Y)N/A-9.57%

Go deeper

Full MPLT analysisFull RZLT analysisInteractive comparison tool

Dig into the metrics

MapLight Therapeutics ROERezolute ROEMapLight Therapeutics operating marginRezolute operating marginMapLight Therapeutics revenue growthRezolute revenue growthMapLight Therapeutics free cash flowRezolute free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.